RIGI and cancer: Recent studies have highlighted antitumor effects of defective viruses, for example, via induction of cell-selective apoptosis in cancer cells through RIG-I-dependent signaling as well as activation of antitumor immunity induced by dendritic cells and T cells (Yang et al. 2019).